Literature DB >> 30712069

C-reactive protein misdiagnoses delayed postoperative spinal implant infections in patients with low-virulent microorganisms.

Doruk Akgün1, Justus Bürger2, Matthias Pumberger3, Michael Putzier1.   

Abstract

PURPOSE: C-reactive protein (CRP) has been shown to be a powerful parameter for detecting acute postoperative spinal implant infections (PSII) with a high sensitivity and specificity. However, little data are available on the performance of CRP in the diagnosis of delayed PSII. The aim of the current study was therefore to establish cutoff values for diagnosing delayed infection based on serum CRP.
METHODS: All patients who underwent a revision surgery after instrumented spinal fusion from January 2013 through January 2016 were included. Demographic data, laboratory values, type of infection (including microbiological and pathological results), comorbidities and clinical manifestation were collected. The European Bone and Joint Infection Society criteria, proposed to diagnose periprosthetic joint infection, were used to diagnose PSII.
RESULTS: A total of 257 patients were included. PSII was diagnosed in 61 patients, representing 24% of the study cohort. There was a significant difference in serum CRP levels between septic and aseptic cohorts (19.3 vs. 4.8 mg/l, p < 0.001). However, 26 patients (43%) from the PSII group had a normal (< 5 mg/l) serum CRP level prior to revision surgery. According to the ROC curve, a serum CRP threshold of 4.05 mg/l had a sensitivity of 64% and specificity of 68%. The most common isolated microorganism was Propionibacterium spp. followed by coagulase-negative staphylococci.
CONCLUSION: Serum CRP showed low sensitivity and specificity for diagnosis of delayed PSII, even after applying cutoffs optimized by using receiver operating curve analysis, because of the high incidence of low-virulent pathogens. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  CRP; Diagnostic; Infection; Posterior fusion; Revision surgery; Spine surgery

Mesh:

Substances:

Year:  2019        PMID: 30712069     DOI: 10.1007/s00586-019-05889-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  21 in total

Review 1.  Pathogenesis and treatment concepts of orthopaedic biofilm infections.

Authors:  Werner Zimmerli; Claus Moser
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-15

2.  Incidence and risk of delayed surgical site infection following instrumented lumbar spine fusion.

Authors:  Peter Lewkonia; Christian DiPaola; John Street
Journal:  J Clin Neurosci       Date:  2015-09-08       Impact factor: 1.961

3.  Association between sciatica and microbial infection: true infection or culture contamination?

Authors:  Peleg Ben-Galim; Nahshon Rand; Michael Giladi; David Schwartz; Ely Ashkenazi; Michael Millgram; Shmuel Dekel; Yizhar Floman
Journal:  Spine (Phila Pa 1976)       Date:  2006-10-01       Impact factor: 3.468

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  The serum level of C-reactive protein alone cannot be used for the diagnosis of prosthetic joint infections, especially in those caused by organisms of low virulence.

Authors:  D Akgün; M Müller; C Perka; T Winkler
Journal:  Bone Joint J       Date:  2018-11       Impact factor: 5.082

6.  Late implant infections caused by Propionibacterium acnes in scoliosis surgery.

Authors:  Frederik Hahn; Reinhard Zbinden; Kan Min
Journal:  Eur Spine J       Date:  2005-04-20       Impact factor: 3.134

7.  Postoperative wound infection after posterior spinal instrumentation: analysis of long-term treatment outcomes.

Authors:  Shih-Hao Chen; Chen-Hsiang Lee; Kuo-Chin Huang; Pang-Hsin Hsieh; Shan-Yin Tsai
Journal:  Eur Spine J       Date:  2014-10-29       Impact factor: 3.134

8.  Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications.

Authors:  James M Mok; Murat Pekmezci; Samantha L Piper; Erin Boyd; Sigurd H Berven; Shane Burch; Vedat Deviren; Bobby Tay; Serena S Hu
Journal:  Spine (Phila Pa 1976)       Date:  2008-02-15       Impact factor: 3.468

9.  Significance of Propionibacterium acnes-positive samples in spinal instrumentation.

Authors:  Pascale Bémer; S Corvec; S Tariel; N Asseray; D Boutoille; C Langlois; B Tequi; H Drugeon; N Passuti; S Touchais
Journal:  Spine (Phila Pa 1976)       Date:  2008-12-15       Impact factor: 3.468

10.  The diagnosis and management of infection following instrumented spinal fusion.

Authors:  Iona Collins; James Wilson-MacDonald; George Chami; Will Burgoyne; P Vinayakam; Tony Berendt; Jeremy Fairbank
Journal:  Eur Spine J       Date:  2007-12-13       Impact factor: 3.134

View more
  4 in total

1.  The role of serum D-Dimer for the diagnosis of periprosthetic shoulder infection.

Authors:  Doruk Akgün; Faisal Al-Muhtaresh; Alp Paksoy; Lucca Lacheta; Marvin Minkus; Daniel Karczewski; Philipp Moroder
Journal:  Arch Orthop Trauma Surg       Date:  2022-02-19       Impact factor: 3.067

2.  Clinical relevance of occult infections in spinal pseudarthrosis revision.

Authors:  Marco D Burkhard; Ali Hassanzadeh; Octavian Andronic; Tobias Götschi; Ilker Uçkay; Mazda Farshad
Journal:  N Am Spine Soc J       Date:  2022-09-21

3.  Postoperative Spinal Implant Infections (PSII)-A Systematic Review: What Do We Know So Far and What is Critical About It?

Authors:  Daniel Karczewski; Klaus J Schnake; Georg Osterhoff; Ulrich Spiegl; Max J Scheyerer; Bernhard Ullrich; Matthias Pumberger
Journal:  Global Spine J       Date:  2021-06-21

4.  The role of serum C-reactive protein in the diagnosis of periprosthetic shoulder infection.

Authors:  Doruk Akgün; Mats Wiethölter; Paul Siegert; Victor Danzinger; Marvin Minkus; Karl Friedrich Braun; Philipp Moroder
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-30       Impact factor: 2.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.